Compare NRIX & FLYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRIX | FLYW |
|---|---|---|
| Founded | 2009 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2020 | 2021 |
| Metric | NRIX | FLYW |
|---|---|---|
| Price | $14.76 | $22.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 15 |
| Target Price | ★ $33.50 | $23.39 |
| AVG Volume (30 Days) | ★ 3.4M | 1.9M |
| Earning Date | 10-12-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 450.00 |
| EPS | ★ 3.26 | 0.61 |
| Revenue | $76,987,000.00 | ★ $623,025,000.00 |
| Revenue This Year | $786.93 | $24.36 |
| Revenue Next Year | N/A | $14.91 |
| P/E Ratio | ★ $4.52 | $36.34 |
| Revenue Growth | ★ 99.31 | 26.59 |
| 52 Week Low | $12.61 | $10.55 |
| 52 Week High | $28.23 | $22.59 |
| Indicator | NRIX | FLYW |
|---|---|---|
| Relative Strength Index (RSI) | 25.08 | 64.50 |
| Support Level | $14.65 | $16.95 |
| Resistance Level | $17.47 | N/A |
| Average True Range (ATR) | 1.22 | 0.95 |
| MACD | -0.77 | 0.16 |
| Stochastic Oscillator | 0.23 | 87.32 |
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements, namely a payments platform, a proprietary payment network, and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.